Principles of Psychopharmacology for Mental Health Professionals
Wiley-Liss Inc.,U.S. (Verlag)
978-0-471-25401-0 (ISBN)
Prepared by world-renowned psychopharmacologists and psychiatrists, this useful resource helps non-prescribing practitioners understand when and why a given medication is appropriate to use, when it is not indicated, and what potential side effects may occur. Also discussed are the appropriate times in therapy when a referral for a medication evaluation is indicated as well as how to broach this issue with the patient. Recognizing that there are almost always a number of medications from which to choose, the authors combine research outcomes with their extensive clinical experience to highlight the important considerations in selecting one medication over another. As an educational tool, the text encourages and supports clinicians who wish to increase patients' understanding of treatment.
After an introduction and overview, chapters cover:
* Basics of psychopharmacology
* Attention-deficit hyperactivity disorder
* Mood disorders
* Sleep disorders
* Schizophrenia
* Cognitive disorders
* Anxiety disorders
* Personality disorders
* Substance use disorders
* Traumatic brain injury
* Eating disorders
* Side effects
Every chapter includes diagnostic considerations, history of medication treatments, and emerging trends for each disease.
Principles of Psychopharmacology for Mental Health Professionals lays out what psychotherapists and other mental health practitioners need to know about psychotropic medications, giving them and their patients an invaluable guide to the full array of treatments available.
Jeffrey E. Kelsey is the author of Principles of Psychopharmacology for Mental Health Professionals, published by Wiley. Charles Barnet Nemeroff is an American psychiatrist known for his work in treating depression. He is the author of numerous textbooks, papers, and clinical studies. D. Jeffrey Newport is the author of Principles of Psychopharmacology for Mental Health Professionals, published by Wiley.
Preface. Faculty Disclosure.
1 INTRODUCTION AND OVERVIEW.
Additional Reading.
2 BASICS OF PSYCHOPHARMACOLOGY.
2.1 Introduction.
2.3 Pathophysiology: Study of What Goes Wrong.
2.4 Pharmacology.
2.5 Putting It All Together.
Additional Reading.
3 MOOD DISORDERS.
3.1 Introduction.
3.2 Major Depressive Disorder.
3.3 Dysthymic Disorder.
3.4 Bipolar Disorders.
Additional Reading.
4 SCHIZOPHRENIA.
4.1 Brief Description and Diagnostic Criteria.
4.2 Prevalence and Risk Factors.
4.3 Presentation and Clinical Course.
4.4 Initial Evaluation and Differential Diagnosis.
4.5 History of Treatment.
4.6 Current Approach to Treatment.
4.7 Treatment Resistant Schizophrenia.
Additional Reading.
5 ANXIETY DISORDERS.
5.1 Introduction.
5.2 Panic Disorder.
5.3 Generalized Anxiety Disorder.
5.4 Obsessive–Compulsive Disorder.
5.5 Social Anxiety Disorder (Social Phobia).
5.6 Post-Traumatic Stress Disorder.
Additional Reading.
6 SUBSTANCE USE DISORDERS.
6.1 Introduction.
6.2 Brief Description and Diagnostic Criteria.
6.3 Prevalence and Risk Factors.
6.4 Presentation and Clinical Course.
6.5 Initial Evaluation and Differential Diagnosis.
6.6 History of Treatment.
6.7 Current Approaches to Treatment.
6.8 Alcohol Use Disorders.
6.9 Cocaine Use Disorders.
6.10 Nicotine Dependence.
6.11 Opiate Use Disorders.
Additional Reading.
7 EATING DISORDERS.
7.1 Introduction.
7.2 Anorexia Nervosa.
7.3 Bulimia Nervosa.
7.4 Binge-Eating Disorder.
Additional Reading.
8 ATTENTION DEFICIT–HYPERACTIVITY DISORDER.
8.1 Brief Description and Diagnostic Criteria.
8.2 Prevalence and Risk Factors.
8.3 Presentation and Clinical Course.
8.4 Initial Evaluation and Differential Diagnosis.
8.5 History of Pharmacological Treatment.
8.6 Current Approach to Treatment.
Additional Reading.
9 SLEEP DISORDERS.
9.1 Introduction.
9.2 Insomnia.
9.3 Narcolepsy.
Additional Reading.
10 ALZHEIMER’S DISEASE AND OTHER DEMENTIAS.
10.1 Brief Description and Diagnostic Criteria.
10.2 Prevalence and Risk Factors.
10.3 Presentation and Clinical Course.
10.4 Initial Evaluation and Differential Diagnosis.
10.5 History of Pharmacological Treatment.
10.6 Current Approach to Treatment.
Additional Reading.
11 PERSONALITY DISORDERS.
11.1 Introduction.
11.2 Cluster A: Odd and Eccentric Personality Disorders.
11.3 Cluster B: Dramatic and Emotional Personality Disorders.
11.4 Cluster C: Anxious and Fearful Personality Disorders.
Additional Reading.
12 TRAUMATIC BRAIN INJURY.
12.1 Introduction.
12.2 Approaches to Treatment.
Additional Reading.
13 MANAGING SIDE EFFECTS.
13.1 Introduction.
13.2 Norepinephrine-Related Side Effects.
13.3 Dopamine-Related Side Effects.
13.4 Serotonin-Related Side Effects.
13.5 GABA-Related Side Effects.
13.6 Acetylcholine-Related Side Effects.
13.7 Histamine-Related Side Effects.
Index.
| Erscheint lt. Verlag | 21.7.2006 |
|---|---|
| Verlagsort | New York |
| Sprache | englisch |
| Maße | 156 x 235 mm |
| Gewicht | 569 g |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Psychiatrie / Psychotherapie |
| ISBN-10 | 0-471-25401-0 / 0471254010 |
| ISBN-13 | 978-0-471-25401-0 / 9780471254010 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
